$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417041661 Filed on August 09, 2017

Income Statement

Concept	2017 Q2	2016 Q4	2016 Q2
Revenue	$3.897M	$3.336M	$2.828M
YoY Change	37.82%	13.79%	22.57%
Cost Of Revenue	$4.062M	$3.560M	$2.969M
YoY Change	36.84%	21.92%	14.16%
Gross Profit	-$165.1K	-$227.8K	-$140.9K
YoY Change	17.13%	-2210.37%	-51.99%
Gross Profit Margin	-4.24%	-6.83%	-4.98%
Selling, General & Admin	$2.073M	$1.740M	$1.973M
YoY Change	5.06%	-13.43%	24.25%
% of Gross Profit
Research & Development	$813.3K	$540.0K	$509.9K
YoY Change	59.49%	-16.92%	79.81%
% of Gross Profit
Depreciation & Amortization	$88.46K	$220.0K	$81.07K
YoY Change	9.12%	10.0%	3.1%
% of Gross Profit
Operating Expenses	$3.117M	$2.510M	$2.690M
YoY Change	15.89%	-11.62%	30.59%
Operating Profit	-$3.283M	-$2.733M	-$2.831M
YoY Change	15.96%	-3.44%	20.63%
Interest Expense	$7.641K	-$10.00K	$9.322K
YoY Change	-18.03%	-50.0%	-32.22%
% of Operating Profit
Other Income/Expense, Net	-$73.10K	-$30.00K	-$71.52K
YoY Change	2.2%		-106.72%
Pretax Income	-$3.356M	-$2.750M	-$2.902M
YoY Change	15.62%	-3.85%	125.22%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.356M	-$2.747M	-$2.902M
YoY Change	15.62%	-4.12%	125.22%
Net Earnings / Revenue	-86.1%	-82.34%	-102.64%
Basic Earnings Per Share
Diluted Earnings Per Share	-$36.69K	-$30.94K	-$38.15K
COMMON SHARES
Basic Shares Outstanding	91.58M shares	90.70M shares	76.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.48M	$13.47M	$2.840M
YoY Change	339.44%	258.24%	-65.37%
Cash & Equivalents	$12.48M	$13.47M
Short-Term Investments
Other Short-Term Assets	$550.0K	$200.0K	$720.0K
YoY Change	-23.61%	-71.83%	56.52%
Inventory	$4.290M	$3.093M	$3.147M
Prepaid Expenses
Receivables	$720.0K	$40.99K	$105.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.04M	$16.80M	$6.811M
YoY Change	164.88%	132.4%	-43.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.272M	$2.435M	$2.415M
YoY Change	-5.92%	-4.74%	-11.09%
Goodwill
YoY Change
Intangibles	$7.444M	$7.390M	$7.385M
YoY Change	0.79%	0.35%	2.49%
Long-Term Investments	$1.366M	$1.020M	$1.081M
YoY Change	26.46%	-16.55%	-12.15%
Other Assets
YoY Change
Total Long-Term Assets	$11.08M	$10.84M	$10.88M
YoY Change	1.85%	-2.02%	-2.4%
TOTAL ASSETS
Total Short-Term Assets	$18.04M	$16.80M	$6.811M
Total Long-Term Assets	$11.08M	$10.84M	$10.88M
Total Assets	$29.12M	$27.64M	$17.69M
YoY Change	64.61%	51.08%	-24.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.269M	$1.340M	$1.567M
YoY Change	44.74%	4.43%	59.18%
Accrued Expenses	$1.500M	$1.600M	$1.191M
YoY Change	25.92%	18.57%	3.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$320.0K	$310.0K	$320.0K
YoY Change	0.0%	0.0%	-3.03%
Total Short-Term Liabilities	$4.087M	$3.249M	$3.305M
YoY Change	23.67%	2.76%	12.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$310.0K
YoY Change	-100.0%	-100.0%	-49.18%
Other Long-Term Liabilities	$140.0K	$60.00K	$120.0K
YoY Change	16.67%	-98.06%	-96.23%
Total Long-Term Liabilities	$140.0K	$60.00K	$430.0K
YoY Change	-67.44%	-98.24%	-88.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.087M	$3.249M	$3.305M
Total Long-Term Liabilities	$140.0K	$60.00K	$430.0K
Total Liabilities	$4.229M	$3.308M	$3.729M
YoY Change	13.39%	-49.63%	-44.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.12M	-$78.14M	-$72.71M
YoY Change	15.68%	17.4%	19.34%
Common Stock	$970.00	$907.00	$760.00
YoY Change	27.63%	27.75%	7.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.89M	$24.33M	$13.96M
YoY Change
Total Liabilities & Shareholders Equity	$29.12M	$27.64M	$17.69M
YoY Change	64.61%	51.08%	-24.0%

Cashflow Statement

Concept	2017 Q2	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	-$3.356M	-$2.747M	-$2.902M
YoY Change	15.62%	-4.12%	125.22%
Depreciation, Depletion And Amortization	$88.46K	$220.0K	$81.07K
YoY Change	9.12%	10.0%	3.1%
Cash From Operating Activities	-$4.350M	-$1.910M	-$3.090M
YoY Change	40.78%	-22.36%	186.11%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$310.0K	-$100.0K
YoY Change	0.0%	181.82%	-28.57%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$130.0K	-$20.00K
YoY Change	-100.0%
Cash From Investing Activities	-$110.0K	-$190.0K	-$120.0K
YoY Change	-8.33%	72.73%	-14.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.210M	10.38M	0.000
YoY Change		-2631.71%	-100.0%
NET CHANGE
Cash From Operating Activities	-4.350M	-1.910M	-3.090M
Cash From Investing Activities	-110.0K	-190.0K	-120.0K
Cash From Financing Activities	6.210M	10.38M	0.000
Net Change In Cash	1.750M	8.280M	-3.210M
YoY Change	-154.52%	-377.85%	-173.79%
FREE CASH FLOW
Cash From Operating Activities	-$4.350M	-$1.910M	-$3.090M
Capital Expenditures	-$100.0K	-$310.0K	-$100.0K
Free Cash Flow	-$4.250M	-$1.600M	-$2.990M
YoY Change	42.14%	-31.91%	218.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1020313	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	109007539	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40992	USD
	xxii	Stock Issued During Period Value Warrants Exercise StockIssuedDuringPeriodValueWarrantsExercise	6212712	USD
CY2017Q2	us-gaap	Equity Method Investments EquityMethodInvestments	1366493	USD
	xxii	Amortization Of License Fees AmortizationOfLicenseFees	49011	USD
	xxii	Amortization Of License Fees AmortizationOfLicenseFees	49011	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	472216	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	322983	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30873	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	440603	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1290331	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	98146	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	355368	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	112862	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	754236	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-158219	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-24339	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5890107	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7051357	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	20596	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	13710	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-121600	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-146769	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	196	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6212712	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6212712	USD
	us-gaap	Accretion Expense AccretionExpense	15560	USD
	us-gaap	Accretion Expense AccretionExpense	19696	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	411472	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	363535	USD
CY2016Q2	us-gaap	Cash Cash	2840577	USD
CY2015Q4	us-gaap	Cash Cash	3760297	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	133059	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	101004	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	550937	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	195569	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2271789	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7443777	USD
CY2017Q2	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8810270	USD
CY2017Q2	us-gaap	Assets Assets	29121706	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2268652	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4086945	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2434663	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7389946	USD
CY2016Q4	xxii	Assests Noncurrent Excluding Property Plant And Equipment Net AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet	8410259	USD
CY2016Q4	us-gaap	Assets Assets	27642357	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1340156	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3249317	USD
CY2017Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	141608	USD
CY2016Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	58681	USD
CY2017Q2	us-gaap	Liabilities Liabilities	4228553	USD
CY2016Q4	us-gaap	Liabilities Liabilities	3307998	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	970	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	102471907	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84115356	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78138455	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	24893153	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	24334359	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29121706	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27642357	USD
CY2017Q2	us-gaap	Notes Payable Current NotesPayableCurrent	320554	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	307938	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6567675	USD
CY2016Q4	xxii	Accrued Severance Liabilities Current AccruedSeveranceLiabilitiesCurrent	199657	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	3092686	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6128723	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	16797435	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1364138	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-142071	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3425597	USD
	us-gaap	Gross Profit GrossProfit	-438952	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6059234	USD
	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	61597	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6154806	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	75027606	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	91165770	shares
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	563304	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2902354	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Depreciation Depreciation	176585	USD
	us-gaap	Depreciation Depreciation	161664	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5976901	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6154806	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	283898	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	250882	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Interest Expense InterestExpense	15560	USD
	us-gaap	Interest Expense InterestExpense	19696	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	27880	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4598	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	322983	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3316601	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	171215	USD
CY2017Q2	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1881233	USD
CY2016Q4	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1936039	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	350623	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	174258	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-10000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0	USD
	xxii	Proceeds From Issuance Registered Direct Offering Three ProceedsFromIssuanceRegisteredDirectOfferingThree	0	USD
	xxii	Proceeds From Issuance Registered Direct Offering Three ProceedsFromIssuanceRegisteredDirectOfferingThree	5091791	USD
	us-gaap	Interest Paid Net InterestPaidNet	2943	USD
	us-gaap	Interest Paid Net InterestPaidNet	19696	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	255623	USD
CY2017Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	756186	USD
CY2016Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	340523	USD
CY2017Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	2001221	USD
CY2016Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1071747	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	143010	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283898	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1058523	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	881938	USD
CY2017Q2	us-gaap	Depreciation Depreciation	88464	USD
CY2017Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.194	pure
CY2014	xxii	Finite Lived Intangible Assets Acquired With Notes Payable FiniteLivedIntangibleAssetsAcquiredWithNotesPayable	925730	USD
CY2014Q4	us-gaap	Other Commitment OtherCommitment	1213000	USD
CY2014Q4	us-gaap	Severance Costs1 SeveranceCosts1	624320	USD
CY2014Q4	xxii	Severance Term SeveranceTerm	P36M
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	525118	shares
CY2016Q2	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	843110	shares
CY2017Q2	xxii	Warrants Expired And Unexercised WarrantsExpiredAndUnexercised	45834	shares
CY2017Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12445247	shares
	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	82927	USD
CY2016	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	29615	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2898296	USD
CY2016	xxii	Reclassification Of Warrant Liability To Capital In Excess Of Par Value ReclassificationOfWarrantLiabilityToCapitalInExcessOfParValue	2810000	USD
CY2016	xxii	Common Stock Warrants Issued Additional Number CommonStockWarrantsIssuedAdditionalNumber	2089	shares
	xxii	Warrants With Provision Of Anti Dilution WarrantsWithProvisionOfAntiDilution	94721	shares
	xxii	Warrants Without Provision Of Anti Dilution WarrantsWithoutProvisionOfAntiDilution	12350526	shares
CY2016	xxii	Warrants Issued In Conjunction With Registered Direct Offering WarrantsIssuedInConjunctionWithRegisteredDirectOffering	2500000	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13781921	shares
CY2016	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	67042	shares
CY2016	xxii	Number Of Warrants Expired NumberOfWarrantsExpired	6831115	shares
CY2016	xxii	Unexercisable Warrants UnexercisableWarrants	2000000	shares
CY2016Q4	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	225000	USD
	xxii	Milestone Payment MilestonePayment	150000	USD
CY2017Q1	us-gaap	License Costs LicenseCosts	85681	USD
CY2014Q3	xxii	License Maintenance Fees Due Current LicenseMaintenanceFeesDueCurrent	75000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	169000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	169000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	169000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	141000	USD
CY2015Q4	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	3750	USD
CY2015Q4	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	25000	sqft
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-3355624	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-2902354	USD
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91577688	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76024064	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	91577688	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	76024064	shares
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91165770	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75027606	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2390000	USD
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0212	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0138	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.9	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y1M17D
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y11D
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	97015911	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90698113	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97015911	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90698113	shares
	us-gaap	Operating Expenses OperatingExpenses	5813522	USD
	us-gaap	Operating Expenses OperatingExpenses	6041967	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	684265	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1138910	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19410935	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15222300	shares
CY2016Q1	xxii	Warrant Exercisable Per Share WarrantExercisablePerShare	3.36
CY2016Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2810000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	79000	USD
	xxii	Patent And Trademark Additions Included In Accrued Expenses PatentAndTrademarkAdditionsIncludedInAccruedExpenses	0	USD
	xxii	Patent And Trademark Additions Included In Accrued Expenses PatentAndTrademarkAdditionsIncludedInAccruedExpenses	30411	USD
CY2016Q2	us-gaap	Depreciation Depreciation	81067	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3330312	USD
CY2017Q2	xxii	Minimum Annual Royalties In Year Three MinimumAnnualRoyaltiesInYearThree	25000	USD
CY2017Q2	xxii	Minimum Annual Royalties After Year Four MinimumAnnualRoyaltiesAfterYearFour	50000	USD
CY2017Q1	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	1219	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong> <strong><font style="FONT-SIZE: 10pt">-</font></strong> <font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	4638640	USD
CY2016Q4	xxii	Inventorytobacco Leaf Net InventorytobaccoLeafNet	3348309	USD
CY2017Q2	xxii	Minimum Annual Royalties In Year One MinimumAnnualRoyaltiesInYearOne	10000	USD
CY2017Q2	xxii	Minimum Annua Lroyalties In Year Two MinimumAnnuaLroyaltiesInYearTwo	15000	USD
CY2017Q2	xxii	Minimum Annual Royalties In Year Four MinimumAnnualRoyaltiesInYearFour	25000	USD
CY2017Q2	xxii	Lease Payments LeasePayments	38438	USD
	xxii	Lease Payments LeasePayments	76876	USD
CY2016Q2	xxii	Lease Payments LeasePayments	36131	USD
	xxii	Lease Payments LeasePayments	72262	USD
CY2016Q2	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	1471	USD
CY2016Q2	xxii	Litigation Settlement Shares To Be Issued LitigationSettlementSharesToBeIssued	2077555	shares
CY2016Q2	xxii	Litigation Settlement Shares To Be Issued LitigationSettlementSharesToBeIssued	2077555	shares
CY2017Q2	us-gaap	Advertising Expense AdvertisingExpense	12000	USD
	us-gaap	Advertising Expense AdvertisingExpense	43000	USD
CY2016Q2	us-gaap	Advertising Expense AdvertisingExpense	27000	USD
	us-gaap	Advertising Expense AdvertisingExpense	235000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	126041	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	250882	USD
CY2017Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1985000	USD
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	3544000	USD
CY2016Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1842000	USD
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	3577000	USD
CY2017Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	320554	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7526	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	14412	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28824	USD
CY2016Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.2	pure
CY2017Q2	xxii	Warrants Outstanding WarrantsOutstanding	12445247	shares
	xxii	June Two Thousand Seventeen Warrant Exercise Agreements Disclosure JuneTwoThousandSeventeenWarrantExerciseAgreementsDisclosure	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">NOTE 2. JUNE 2017 WARRANT EXERCISE AGREEMENTS</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"> </font></b></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On June 19, 2017, the Company entered into Warrant Exercise Agreements (the “Agreements”) with all of the holders (the “Holders”) of outstanding warrants to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,043,211</font> shares of common stock of the Company at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.00</font> per share and warrants to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,250,000</font> shares of common stock of the Company at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.45</font> per share (collectively, the “Warrants”). These Warrants to purchase shares of the Company’s common stock were acquired by the Holders in registered direct offerings in October of 2016 and in July of 2016, respectively, as more fully described in Notes 3 and 4 below. The Company and the Holders agreed that the Holders would, subject to beneficial ownership limitations on exercise contained in the Warrants, exercise all the Warrants for cash. In June 2017, the Holders exercised <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,229,711</font> Warrants at $1.00 per share and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,354,948</font> Warrants at $1.45 per share, resulting in net proceeds to the Company in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,169,212</font>, after deducting expenses associated with the transaction.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In consideration for the Holders exercising their Warrants for cash, the Company issued to each Holder a new warrant (the “New Warrants”) to purchase shares of common stock of the Company equal to the number of shares of common stock received by each Holder upon the cash exercise of the Holder’s Warrants. The terms of the New Warrants are substantially similar to the terms of the Warrants exercised, except the New Warrants (i) have an exercise price equal to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.15</font> per share and (ii) <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">are exercisable six months from the date of issuance of the New Warrants for a period of five (5) years.</font> Accordingly, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,584,659</font> New Warrants to the Holders on June 20, 2017, upon exercise of the Holder’s Warrants as described above. The New Warrants had a fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,913,808</font> at issuance and have been recorded as an adjustment to capital in excess of par. As described in Note 16, additional Warrants were exercised in July and August of 2017 for cash, for a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,708,552</font> Warrants exercised, generating net proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,167,646</font>, and the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,708,552</font> New Warrants.</font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	5657159	shares
CY2017Q1	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	202500	shares
CY2017Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100928	shares
CY2017Q1	xxii	Warrants Expired And Unexercised WarrantsExpiredAndUnexercised	172730	shares
CY2016Q1	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	67042	shares
CY2016Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2618	shares
CY2016Q1	xxii	Warrants Expired And Unexercised WarrantsExpiredAndUnexercised	6831115	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4250000	shares
CY2017Q2	xxii	Minimum Royalty Fee Payments Due In Year Four MinimumRoyaltyFeePaymentsDueInYearFour	31709	USD
CY2018Q4	xxii	Minimum Annual Royalties In Year Three MinimumAnnualRoyaltiesInYearThree	4866	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3897206	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2827658	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4062261	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2968571	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	-165055	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	-140913	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	813287	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	509928	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1805118	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1721775	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	267591	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	251106	USD
CY2017Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	77583	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	82927	USD
CY2016Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	9468	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	61597	USD
CY2017Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	143010	USD
CY2016Q2	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	126041	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	3117470	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2689917	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3282525	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2830830	USD
CY2017Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	-77583	USD
CY2016Q2	xxii	Gain Loss From Warrant Liability GainLossFromWarrantLiability	-9468	USD
CY2017Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2016Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-54839	USD
CY2017Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	12125	USD
CY2016Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2105	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	7641	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	9322	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-73099	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-71524	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3355624	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	-95000	USD
	xxii	Inventory Reserve Adjustments InventoryReserveAdjustments	0	USD
	xxii	Reclassification Of Warrants Liability To Capital In Excess Of Par Value ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue	2810000	USD
	xxii	Reclassification Of Warrants Liability To Capital In Excess Of Par Value ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue	0	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	16634778	shares

Files In Submission

Name	View Source	Status
0001144204-17-041661-index-headers.html	Edgar Link	pending
0001144204-17-041661-index.html	Edgar Link	pending
0001144204-17-041661.txt	Edgar Link	pending
0001144204-17-041661-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v471703_10q.htm	Edgar Link	pending
v471703_ex31-1.htm	Edgar Link	pending
v471703_ex31-2.htm	Edgar Link	pending
v471703_ex32-1.htm	Edgar Link	pending
xxii-20170630.xml	Edgar Link	completed
xxii-20170630.xsd	Edgar Link	pending
xxii-20170630_cal.xml	Edgar Link	unprocessable
xxii-20170630_def.xml	Edgar Link	unprocessable
xxii-20170630_lab.xml	Edgar Link	unprocessable
xxii-20170630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2017 Q2 Form 10-Q Financial Statement

#000114420417041661 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2017 Q2 Form 10-Q Financial Statement

#000114420417041661 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii